Comparison of the Efficacy of Innovator Rituximab and its Biosimilars in Diffuse Large B Cell Lymphoma Patients: A Retrospective Analysis

Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma among adults, although it also affects the young and the elderly. DLBCL is treated with a chimeric monoclonal antibody against CD20, a B cell surface protein, named rituximab, in combination with a multidrug chemot...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Indian J Hematol Blood Transfus
Hoofdauteurs: Bankar, Aniket, Korula, Anu, Abraham, Aby, Viswabandya, Auro, George, Biju, Srivastava, Alok, Mathews, Vikram
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer India 2019
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042466/
https://ncbi.nlm.nih.gov/pubmed/32174693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-019-01167-w
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items